Clinical Trials Logo

Clinical Trial Summary

Purpose: To evaluate the acute changes in intraocular cytokines after intravitreal bevacizumab (IVB) in proliferative diabetic retinopathy.

Design: Prospective, open-label, controlled, randomized interventional clinical trial.

Participants: Twenty eyes of 28 consecutive patients who are scheduled for pars plana vitrectomy (ppV) for proliferative diabetic retinopathy were prospectively enrolled.

Methods: All patients were randomly assigned to receive IVB either at 2 or 7 days before ppV. Aqueous humor samples were taken from anterior chamber just before IVB and at the time of surgery. Multiplex cytokine array were used to assay various cytokines


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01439178
Study type Interventional
Source Seoul St. Mary's Hospital
Contact Won Ki Lee, MD. Ph.D
Phone 82-2-2258-1188
Email wklee@catholic.ac.kr
Status Recruiting
Phase N/A
Start date August 2011
Completion date November 2011

See also
  Status Clinical Trial Phase
Completed NCT02335931 - Characterization of the Charcot Foot
Completed NCT01926522 - Technological Rehabilitation of Distal Sensorimotor Polyneuropathy in Diabetic Patients N/A
Recruiting NCT02718547 - The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema N/A
Completed NCT02478190 - ED Management of Severe Hyperglycemia: A Clinical Trial N/A
Completed NCT03208309 - Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin Phase 2
Completed NCT03530176 - 18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes N/A
Completed NCT01821508 - Clinical Study on Metabolic Surgery Compared to the Best Clinical Treatment in Patients With Type 2 Diabetes Mellitus N/A